Pharma Consulting During COVID Times with Martin Lessem

Adam Torres and Martin Lessem discuss the consulting landscape.

Subscribe: iTunes / Spotify / Stitcher / RSS

Apply to be a guest on our podcast here

Show Notes:

COVID has changed the way many industries function with even the pharma landscape being affected. In this episode,  Adam Torres and Martin Lessem, Principal Consultant and Founder at Lessem Regulatory Consulting Group, LLC, explore the pharma industry and how Lessem Regulatory Consulting Group is playing it’s role.

About Martin Lessem

Martin is a Regulatory Professional with 13 years of experience in Industry. He has worked on INDs, NDAs, BLAs, NDSs, MAAs and additional supplemental filings for these, as well as Regulatory Risk Management, Regulatory Drug Safety, Competitive Intelligence, and Post-Marketing, among other areas. Additionally he has experience in directing and leading meetings and communications with Health Authorities.

About Lessem Regulatory Consulting, LLC

Lessem Regulatory Consulting Group, LLC (LRCG) is a Boston based consulting firm specializing in Regulatory consulting for the Pharma and BioTech industry.

LRCG brings 15 years of Regulatory and Pharmaceutical experience to bear in strategic solutions for the consumer. With work in all areas of the drug development process from the IND on through Post-Marketing, LRCG can guide you toward successful development of your product, through a robust Regulatory Strategy. This includes exploring expedited approval pathways, coordinating Health Authority interactions, review of documents, labeling strategy, Regulatory Risk Management, and helping to set-up a Regulatory Department where needed, including creating SOPs and procedures. 

This image has an empty alt attribute; its file name is Final-VIP-UPGRADE-Banner-1-1024x162.png